Dexcom CTO Jake Leach

“As Interoperable As Possible” – Talking to Dexcom CTO Jake Leach

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/14888987/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/3e9ccc/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_307_final_Dexcom_Leach_ADA_2020.mp3″ libsyn_item_id=”14888987″ height=”90″ theme=”custom” custom_color=”3e9ccc” player_use_thumbnail=”use_thumbnail” use_download_link=”use_download_link” download_link_text=”Download” /] Digging deeper into recent news from and about Dexcom. Stacey talks to Chief Technology Officer Jake Leach about the news that competitor Abbott has received approval for it’s Libre 2 CGM. What does that mean for the marketplace? She…